[EN] NOVEL TRANSCRIPTION FACTOR MODULATORS<br/>[FR] NOUVEAUX MODULATEURS DE FACTEURS DE TRANSCRIPTION
申请人:C & C BIOPHARMA LLC
公开号:WO2014138508A1
公开(公告)日:2014-09-12
The present disclosure provides novel compounds capable of functioning as transcription factor modulators, as well as compositions, pharmaceutical formulations, and kits. Also provided are methods of treating a condition regulatable by a transcription factor and/or cofactor using the compounds, compositions, pharmaceutical formulations, and kits provided herein. Alterations of epigenetic regulation are a characteristic of many diseases. The myocyte enhancer factor 2 (MEF2) transcription factor plays central roles in the transmission of extracellular signals to the genome and in the activation of the genetic programs that control cell differentiation, proliferation, morphogenesis, survival and apoptosis of a wide range of cell types (Potthoff et al., 2007).